10-49470676-G-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000124.4(ERCC6):​c.3284C>G​(p.Pro1095Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00223 in 1,613,920 control chromosomes in the GnomAD database, including 79 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1095A) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.012 ( 39 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 40 hom. )

Consequence

ERCC6
NM_000124.4 missense

Scores

2
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:10

Conservation

PhyloP100: 2.12

Publications

12 publications found
Variant links:
Genes affected
ERCC6 (HGNC:3438): (ERCC excision repair 6, chromatin remodeling factor) This gene encodes a DNA-binding protein that is important in transcription-coupled excision repair. The encoded protein has ATP-stimulated ATPase activity, interacts with several transcription and excision repair proteins, and may promote complex formation at DNA repair sites. Mutations in this gene are associated with Cockayne syndrome type B and cerebrooculofacioskeletal syndrome 1. Alternative splicing occurs between a splice site from exon 5 of this gene to the 3' splice site upstream of the open reading frame (ORF) of the adjacent gene, piggyback-derived-3 (GeneID:267004), which activates the alternative polyadenylation site downstream of the piggyback-derived-3 ORF. The resulting transcripts encode a fusion protein that shares sequence with the product of each individual gene. [provided by RefSeq, Mar 2016]
ERCC6 Gene-Disease associations (from GenCC):
  • Cockayne spectrum with or without cerebrooculofacioskeletal syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Cockayne syndrome type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Orphanet, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • UV-sensitive syndrome 1
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • COFS syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • UV-sensitive syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • premature ovarian failure 11
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.035110116).
BP6
Variant 10-49470676-G-C is Benign according to our data. Variant chr10-49470676-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1707.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0118 (1797/152238) while in subpopulation AFR AF = 0.0413 (1717/41538). AF 95% confidence interval is 0.0397. There are 39 homozygotes in GnomAd4. There are 800 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 39 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ERCC6NM_000124.4 linkc.3284C>G p.Pro1095Arg missense_variant Exon 18 of 21 ENST00000355832.10 NP_000115.1 Q03468-1Q59FF6
ERCC6NM_001346440.2 linkc.3284C>G p.Pro1095Arg missense_variant Exon 18 of 21 NP_001333369.1 Q03468-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ERCC6ENST00000355832.10 linkc.3284C>G p.Pro1095Arg missense_variant Exon 18 of 21 1 NM_000124.4 ENSP00000348089.5 Q03468-1

Frequencies

GnomAD3 genomes
AF:
0.0118
AC:
1795
AN:
152120
Hom.:
39
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0414
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00766
GnomAD2 exomes
AF:
0.00299
AC:
750
AN:
251036
AF XY:
0.00203
show subpopulations
Gnomad AFR exome
AF:
0.0425
Gnomad AMR exome
AF:
0.00147
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000264
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.00124
AC:
1810
AN:
1461682
Hom.:
40
Cov.:
34
AF XY:
0.00106
AC XY:
768
AN XY:
727146
show subpopulations
African (AFR)
AF:
0.0466
AC:
1561
AN:
33476
American (AMR)
AF:
0.00159
AC:
71
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39686
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53288
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000171
AC:
19
AN:
1111972
Other (OTH)
AF:
0.00238
AC:
144
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
98
197
295
394
492
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0118
AC:
1797
AN:
152238
Hom.:
39
Cov.:
32
AF XY:
0.0107
AC XY:
800
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.0413
AC:
1717
AN:
41538
American (AMR)
AF:
0.00392
AC:
60
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4812
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10598
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68022
Other (OTH)
AF:
0.00758
AC:
16
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
93
187
280
374
467
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000618
Hom.:
1
Bravo
AF:
0.0134
ESP6500AA
AF:
0.0399
AC:
176
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00378
AC:
459
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:10
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 21, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 9443879, 20981092, 22995991) -

Sep 15, 2014
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ERCC6: BP4, BS1, BS2 -

not specified Uncertain:1Benign:2
Aug 26, 2013
Claritas Genomics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 10, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 11, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Cockayne syndrome type 2 Uncertain:1Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Jan 01, 1998
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Age related macular degeneration 5 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Cerebrooculofacioskeletal syndrome 1 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

DE SANCTIS-CACCHIONE SYNDROME Benign:1
Aug 22, 2023
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.077
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
12
DANN
Benign
0.80
DEOGEN2
Benign
0.065
T
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.74
FATHMM_MKL
Uncertain
0.79
D
LIST_S2
Benign
0.46
T
MetaRNN
Benign
0.035
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
2.1
PrimateAI
Benign
0.22
T
PROVEAN
Benign
-0.45
N
REVEL
Benign
0.10
Sift
Benign
0.54
T
Sift4G
Benign
0.52
T
Polyphen
0.0
B
Vest4
0.064
MVP
0.43
MPC
0.11
ClinPred
0.0061
T
GERP RS
1.2
Varity_R
0.018
gMVP
0.27
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4253208; hg19: chr10-50678722; COSMIC: COSV99054175; COSMIC: COSV99054175; API